Dawn Bell
Company: Mryacle
Job title: Co-Founder and Director
Seminars:
Elevating Safety & Adherence Through Feature Differentiation 2:15 pm
Addressing phenotype heterogeneity through combination drugs Translating learning from non-responsiveness to GLPs Redefining treatment based on differential comorbiditiesRead more
day: Conference Day One
Panel Discussion & Extended Q&A: Interrogating the Roadmap From Experimental to Validated – Moving Beyond GLP-1Rs into Poly-Pharmacology 3:45 pm
day: Conference Day One